Skip to main content
Erschienen in: Annals of Nuclear Medicine 7/2017

03.05.2017 | Original Article

FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study

verfasst von: Hidenori Suzuki, Katsuhiko Kato, Masami Nishio, Tsuneo Tamaki, Yasushi Fujimoto, Mariko Hiramatsu, Nobuhiro Hanai, Takeshi Kodaira, Yoshiyuki Itoh, Shinji Naganawa, Michihiko Sone, Yasuhisa Hasegawa

Erschienen in: Annals of Nuclear Medicine | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We investigated a possible correlation between the maximum standardized uptake value (SUVmax), which is assessed by pretreatment 18F-fluorodeoxyglucose positron emission tomography with computed tomography, and the overall survival (OS) in patients with hypopharyngeal squamous cell carcinoma from two institutions on long-term follow-up, and examined whether SUVmax is correlated with several survival outcomes, including lung metastasis-free survival.

Methods

A total of 81 patients were enrolled. The survival rate was calculated by the Kaplan–Meier method. Both univariate and multivariate survival analyses were assessed by a Cox proportional hazards model.

Results

SUVmax ≥15.2 in institution A (p = 0.0306) or SUVmax ≥8 in institution B (p = 0.0132) was significantly predictor of a lower OS. We disaggregated the data by high SUVmax (SUVmax ≥15.2 from institution A and SUVmax ≥8 from institution B) and low SUVmax (SUVmax <15.2 from institution A and SUVmax <8 from institution B). Patients with a high SUVmax exhibited a significantly lower OS in both univariate (p = 0.001) and multivariate (p = 0.0046) analyses for adjusted for the clinical stage and treatment group. The patients with a high SUVmax exhibited significantly shorter disease-specific (p = 0.0068), distant metastasis-free (p = 0.0428), and lung metastasis-free (p = 0.0328) survivals.

Conclusions

High SUVmax was significantly correlated with a lower OS, disease-specific survival, distant metastasis-free survival, and lung metastasis-free survival in a multi-institutional retrospective study.
Literatur
1.
Zurück zum Zitat Paidpally V, Chirindel A, Lam S, Agrawal N, Quon H, Subramaniam RM. FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med. 2012;4:633–47.CrossRefPubMedPubMedCentral Paidpally V, Chirindel A, Lam S, Agrawal N, Quon H, Subramaniam RM. FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med. 2012;4:633–47.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Suzuki H, Nishio M, Nakanishi H, Hanai N, Hirakawa H, Kodaira T, et al. Impact of total lesion glycolysis measured by 18F-FDG-PET/CT on overall survival and distant metastasis in hypopharyngeal cancer. Oncol Lett. 2016;12:1493–500.PubMedPubMedCentral Suzuki H, Nishio M, Nakanishi H, Hanai N, Hirakawa H, Kodaira T, et al. Impact of total lesion glycolysis measured by 18F-FDG-PET/CT on overall survival and distant metastasis in hypopharyngeal cancer. Oncol Lett. 2016;12:1493–500.PubMedPubMedCentral
3.
Zurück zum Zitat Suzuki H, Kato K, Fujimoto Y, Itoh Y, Hiramatsu M, Maruo T, et al. 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma. Ann Nucl Med. 2013;27:297–302.CrossRefPubMed Suzuki H, Kato K, Fujimoto Y, Itoh Y, Hiramatsu M, Maruo T, et al. 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma. Ann Nucl Med. 2013;27:297–302.CrossRefPubMed
4.
Zurück zum Zitat Suzuki H, Hasegawa Y, Terada A, Hyodo I, Nakashima T, Nishio M, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol. 2009;45:569–73.CrossRefPubMed Suzuki H, Hasegawa Y, Terada A, Hyodo I, Nakashima T, Nishio M, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol. 2009;45:569–73.CrossRefPubMed
5.
Zurück zum Zitat Schwartz DL, Rajendran J, Yueh B, Coltera MD, Leblanc M, Eary J, et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg. 2004;130:1361–7.CrossRefPubMed Schwartz DL, Rajendran J, Yueh B, Coltera MD, Leblanc M, Eary J, et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg. 2004;130:1361–7.CrossRefPubMed
6.
Zurück zum Zitat Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, et al. Prognostic value of 18F-FDG-PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol. 2009;192:W156–60.CrossRefPubMed Torizuka T, Tanizaki Y, Kanno T, Futatsubashi M, Naitou K, Ueda Y, et al. Prognostic value of 18F-FDG-PET in patients with head and neck squamous cell cancer. AJR Am J Roentgenol. 2009;192:W156–60.CrossRefPubMed
7.
Zurück zum Zitat van Baardwijk A, Dooms C, van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and Glut-1 in non-small cell lung cancer. Eur J Cancer. 2007;43:1392–8.CrossRefPubMed van Baardwijk A, Dooms C, van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and Glut-1 in non-small cell lung cancer. Eur J Cancer. 2007;43:1392–8.CrossRefPubMed
8.
Zurück zum Zitat Suzuki H, Beppu S, Hanai N, Hirakawa H, Hasegawa Y. Lymph node density predicts lung metastasis in oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2016;54:213–8.CrossRefPubMed Suzuki H, Beppu S, Hanai N, Hirakawa H, Hasegawa Y. Lymph node density predicts lung metastasis in oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2016;54:213–8.CrossRefPubMed
9.
Zurück zum Zitat Inohara H, Enomoto K, Tomiyama Y, Higuchi I, Inoue T, Hatazawa J. Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma. Mol Imaging Biol. 2010;12:89–97.CrossRefPubMed Inohara H, Enomoto K, Tomiyama Y, Higuchi I, Inoue T, Hatazawa J. Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma. Mol Imaging Biol. 2010;12:89–97.CrossRefPubMed
10.
Zurück zum Zitat Schwartz DL, Harris J, Yao M, Rosenthal DI, Opanowski A, Levering A, et al. Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522. Int J Radiat Oncol Biol Phys. 2015;91:721–9.CrossRefPubMedPubMedCentral Schwartz DL, Harris J, Yao M, Rosenthal DI, Opanowski A, Levering A, et al. Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522. Int J Radiat Oncol Biol Phys. 2015;91:721–9.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Xie P, Li M, Zhao H, Sun X, Fu Z, Yu J. 18F-FDG PET or PET–CT to evaluate prognosis for head and neck cancer: a meta-analysis. J Cancer Res Clin Oncol. 2011;131:1085–93.CrossRef Xie P, Li M, Zhao H, Sun X, Fu Z, Yu J. 18F-FDG PET or PET–CT to evaluate prognosis for head and neck cancer: a meta-analysis. J Cancer Res Clin Oncol. 2011;131:1085–93.CrossRef
12.
Zurück zum Zitat Zhang B, Geng J, Nie F, Li X. Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma. Oncol Res Treat. 2015;38:45–8.CrossRefPubMed Zhang B, Geng J, Nie F, Li X. Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma. Oncol Res Treat. 2015;38:45–8.CrossRefPubMed
13.
Zurück zum Zitat Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz M Jr, Wolf GT, et al. Current trends in initial management of hypopharyngeal caner: the declining use of open surgery. Head Neck. 2012;34:270–81.CrossRefPubMed Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz M Jr, Wolf GT, et al. Current trends in initial management of hypopharyngeal caner: the declining use of open surgery. Head Neck. 2012;34:270–81.CrossRefPubMed
14.
Zurück zum Zitat Tai SK, Yang MH, Wang LW, Tsai TL, Chu PY, Wang YF, et al. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer. Jpn J Clin Oncol. 2008;38:521–7.CrossRefPubMed Tai SK, Yang MH, Wang LW, Tsai TL, Chu PY, Wang YF, et al. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer. Jpn J Clin Oncol. 2008;38:521–7.CrossRefPubMed
15.
Zurück zum Zitat Nakahara R, Kodaira T, Furutani K, Tachibana H, Tomita N, Inokuchi H, et al. Treatment outcomes of definitive chemoradiotherapy for patients with hypopharygneal cancer. J Radiat Res. 2012;53:906–15.CrossRefPubMedPubMedCentral Nakahara R, Kodaira T, Furutani K, Tachibana H, Tomita N, Inokuchi H, et al. Treatment outcomes of definitive chemoradiotherapy for patients with hypopharygneal cancer. J Radiat Res. 2012;53:906–15.CrossRefPubMedPubMedCentral
Metadaten
Titel
FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study
verfasst von
Hidenori Suzuki
Katsuhiko Kato
Masami Nishio
Tsuneo Tamaki
Yasushi Fujimoto
Mariko Hiramatsu
Nobuhiro Hanai
Takeshi Kodaira
Yoshiyuki Itoh
Shinji Naganawa
Michihiko Sone
Yasuhisa Hasegawa
Publikationsdatum
03.05.2017
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 7/2017
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-017-1176-1

Weitere Artikel der Ausgabe 7/2017

Annals of Nuclear Medicine 7/2017 Zur Ausgabe